Literature DB >> 2068098

Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors.

S Candéias1, J Katz, C Benoist, D Mathis, K Haskins.   

Abstract

Nonobese diabetic (NOD) mice spontaneously develop a T-cell-mediated autoimmune disease that is similar in many respects to insulin-dependent diabetes mellitus in humans. T-cell clones that specifically recognize pancreatic islet cell antigens can be derived from NOD mice, and most of these have been diabetogenic upon transfer to healthy recipients. We report herein the sequences of the T-cell receptor alpha and beta chains from four NOD-derived, islet-specific clones. The sequences are quite heterogeneous--in the junctional regions, specifically--so there seems to be little hope for treating this disease with specific anti-T-cell receptor reagents. This result contrasts with the strikingly restricted junctional region sequences reported for the receptors on clones derived from mice with experimental allergic encephalomyelitis, another T-cell-mediated autoimmune disease. We discuss possible explanations for this difference.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068098      PMCID: PMC52043          DOI: 10.1073/pnas.88.14.6167

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides.

Authors:  M D Howell; S T Winters; T Olee; H C Powell; D J Carlo; S W Brostoff
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

2.  The structure of V alpha and J alpha segments in the mouse.

Authors:  J Yague; M Blackman; W Born; P Marrack; J Kappler; E Palmer
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

3.  T-lymphocyte clone specific for pancreatic islet antigen.

Authors:  K Haskins; M Portas; B Bradley; D Wegmann; K Lafferty
Journal:  Diabetes       Date:  1988-10       Impact factor: 9.461

4.  Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis.

Authors:  A A Vandenbark; G Hashim; H Offner
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

Review 5.  The T-cell receptor repertoire and autoimmune diseases.

Authors:  V Kumar; D H Kono; J L Urban; L Hood
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

6.  The T cell receptor V alpha 3 gene segment is associated with reactivity to p-azobenzenearsonate.

Authors:  K N Tan; B M Datlof; J A Gilmore; A C Kronman; J H Lee; A M Maxam; A Rao
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

7.  An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.

Authors:  E P Reich; R S Sherwin; O Kanagawa; C A Janeway
Journal:  Nature       Date:  1989-09-28       Impact factor: 49.962

8.  Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.

Authors:  Y Yanagi; R Maekawa; T Cook; O Kanagawa; M B Oldstone
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

9.  Pancreatic islet-specific T-cell clones from nonobese diabetic mice.

Authors:  K Haskins; M Portas; B Bergman; K Lafferty; B Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy.

Authors:  J L Urban; V Kumar; D H Kono; C Gomez; S J Horvath; J Clayton; D G Ando; E E Sercarz; L Hood
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

View more
  31 in total

Review 1.  Non-obese diabetic transgenic mouse.

Authors:  K Yamamura; T Miyazaki; M Uno; T Toyonaga; J Miyazaki
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

3.  Induction of diabetes with islet-specific T-cell clones is age dependent.

Authors:  J D Peterson; B Pike; A Dallas-Pedretti; K Haskins
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

Review 4.  The immunologic insult in type 1 diabetes.

Authors:  M C Honeyman; L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1993

Review 5.  Cellular basis of T-cell autoreactivity in autoimmune diseases.

Authors:  C Carnaud; J F Bach
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

6.  Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.

Authors:  B Anderson; B J Park; J Verdaguer; A Amrani; P Santamaria
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

7.  Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.

Authors:  Thomas Stratmann; Natalia Martin-Orozco; Valérie Mallet-Designe; Laurent Poirot; Dorian McGavern; Grigoriy Losyev; Cathleen M Dobbs; Michael B A Oldstone; Kenji Yoshida; Hitoshi Kikutani; Diane Mathis; Christophe Benoist; Kathryn Haskins; Luc Teyton
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

8.  A comparative study of T-cell receptor V beta usage in non-obese diabetic (NOD) and I-E transgenic NOD mice.

Authors:  N M Parish; H Acha-Orbea; E Simpson; S X Qin; T Lund; A Cooke
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

9.  Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.

Authors:  N Chosich; L C Harrison
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

Review 10.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.